id: 38
text:  good. Initiating large-scale serological testing initiatives is key to proactive approaches to end the COVID-19 pandemic and enable economic re-engagement. ensuring the final outbreak concludes with less than 25% of the population having been infected compared to the expectation of ~90% in the absence of shielding. We use our core shielding model as the basis for application to COVID-19, as it represents the conservative benefits of shielding; how
